InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
7
T+90 hit rate
0%
T+90 mean return
-18.5%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Cummings Keith Lamont, Chief Financial Officer. Director active across 1 company, notably Pliant Therapeutics, INC.. Aggregated, 21 disclosures have been recorded. Breakdown: 0 buy · 7 sells. Total volume traded: €1.1m. Activity tracked since 3 September 2021. The latest transaction was disclosed on 20 January 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations21 total
24,002 shares@ US$1.280.035% mcap21.5% of flowCommon StockSEC:0001746473-26-000012:0
24,002 shares@ US$1.2821.5% of flowCommon StockSEC:0001746473-26-000012
56,650 shares0Common StockSEC:0001746473-25-000011:0
20,148 shares@ US$11.201116.7% of flowCommon StockSEC:0001746473-25-000005:0
10,911 shares@ US$11.568.9% of flowCommon StockSEC:0001746473-24-000125:0
21,313 shares0Common StockSEC:0001746473-24-000115:0
21,000 shares@ US$2.083.1% of flowCommon StockSEC:0001746473-24-000063:0
55,250 shares0Common StockSEC:0001746473-24-000014:0
9,781 shares@ US$17.2311.8% of flowCommon StockSEC:0001746473-24-000005:0
19,771 shares@ US$18.009124.1% of flowCommon StockSEC:0001209191-23-042825:0
38,750 shares0Common StockSEC:0001209191-23-042656:0
30,750 shares@ US$2.084.5% of flowCommon StockSEC:0001209191-23-037143:0
5,800 shares@ US$2.080.9% of flowCommon StockSEC:0001209191-23-036465:0
9,960 shares@ US$26.520918.4% of flowCommon StockSEC:0001209191-23-022364:0
19,375 shares0Common StockSEC:0001209191-23-021917:0
54,000 shares0Common StockSEC:0001140361-23-003181:0
12,500 shares@ US$2.081.8% of flowCommon StockSEC:0001140361-23-002783:0
4,000 shares@ US$2.080.6% of flowCommon StockSEC:0001140361-22-047041:0
19,375 shares0Common StockSEC:0001140361-22-046571:0
20,000 shares@ US$2.080.047% mcap28.5% of flowCommon StockSEC:0001209191-21-054876:0
20,000 shares@ US$2.080.047% mcap57.0% of flowCommon StockSEC:0001209191-21-054876
21 of 21 declarations
About Cummings Keith Lamont
Keith Lamont Cummings is the Chief Financial Officer at Pliant Therapeutics, Inc. He oversees the financial operations of the company, ensuring compliance and efficiency in financial processes. His expertise is essential for Pliant's financial management.
